[1]
2026. Study of the use of zoledronic acid in pediatric patients with osteogenesis imperfecta at the Fernandes Figueira Institute (IFF/Fiocruz). Research, Society and Development. 15, 1 (Jan. 2026), e0615150474. DOI:https://doi.org/10.33448/rsd-v15i1.50474.